Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

BACKGROUND: The newly discovered coronavirus has turned into coronavirus disease 2019 (COVID-19) pandemic and it rages at an unprecedented rate. Considering the findings of previous studies on the use of Intravenous Immunoglobulin (IVIg) for treating severe H(1)N(1) infection and the satisfying resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabarsi, Payam, Barati, Saghar, Jamaati, Hamidreza, Haseli, Sara, Marjani, Majid, Moniri, Afshin, Abtahian, Zahra, Dastan, Alireza, Yousefian, Sahar, Eskandari, Raha, Saffaei, Ali, Monjazebi, Fatemeh, Vahedi, Abdolbaset, Dastan, Farzaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665876/
https://www.ncbi.nlm.nih.gov/pubmed/33214093
http://dx.doi.org/10.1016/j.intimp.2020.107205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665876/
https://www.ncbi.nlm.nih.gov/pubmed/33214093
http://dx.doi.org/10.1016/j.intimp.2020.107205

Ejemplares similares